Object. Transplantation of fetal dopaminergic tissue is being investigated in animal models and clinical trials for its potential as a treatment for advanced Parkinson disease. At the same time, the availability of fetal tissue is limited, making its storage time prior to transplantation a key practical issue. Although it results in a smaller percentage of surviving cells, a longer storage time enables fetal tissue obtained over several days to be pooled for transplantation in a recipient. Glial cell line—derived neurotrophic factor (GDNF) has been shown to improve survival of human dopaminergic tissue that has been stored prior to transplantation. The objective of this study was to evaluate the effects on fetal dopaminergic tissue of GDNF-supplemented hibernation for extended periods of 6 to 15 days.
Methods. The ventral mesencephalon (VM) was harvested in a total of 27 14-day-old rat fetuses, and three VMs were cultured immediately (fresh control group). The remaining 24 VMs were divided sagittally along the midline to yield 48 equal pieces of hemimesencephalon. Twenty-four pieces were stored with GDNF-supplemented hibernation medium for 6, 9, 12, or 15 days, and the 24 “partner” hemimesencephalon pieces were stored in control hibernation medium for the same periods of time. Tissue was cultured for 48 hours and processed for tyrosine hydroxylase (TH) immunoreactivity and double-stained with cresyl violet. Cell counts for all cultures and the percentage of TH-immunoreactive cells were obtained. The percentage of TH-immunoreactive cells for the fresh control group was 6.3 ± 0.5%. The percentage of TH-immunoreactive cells in cultures derived from tissue stored in GDNF-supplemented medium was significantly increased at 6 and 9 days posthibernation compared with the fresh control group and the “partner” groups stored in hibernation medium only. No significant increase in the percentage of TH-immunoreactive cells was observed in the 12- and 15-day groups.
Conclusions. In this study the authors have demonstrated that fetal dopaminergic tissue can be safely stored for up to 9 days in GDNF-supplemented hibernation medium. Furthermore, the percentage of TH-immunoreactive cells is significantly increased after 6 and 9 days of storage in this medium, improving the yield of TH-immunoreactive cells prior to transplantation. These observations have practical clinical implications for collecting fetal dopaminergic cells and improving their survival after transplantation.
Apostolides C, , Sanford E, & Hong M, et al: Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells. Neuroscience 83:363–372, 1998 Apostolides C, Sanford E, Hong M, et al: Glial cell line-derived neurotrophic factor improves intrastriatal graft survival of stored dopaminergic cells. Neuroscience 83:363–372, 1998
Bjorklund A, & Stenevi U: Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177:555–560, 1979 Bjorklund A, Stenevi U: Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants. Brain Res 177:555–560, 1979
Brundin P, , Strecker RE, & Widner H, et al: Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behavior, and dopamine release. Exp Brain Res 70:192–208, 1988 Brundin P, Strecker RE, Widner H, et al: Human fetal dopamine neurons grafted in a rat model of Parkinson's disease: immunological aspects, spontaneous and drug-induced behavior, and dopamine release. Exp Brain Res 70:192–208, 1988
Collier TJ, , Gallagher MJ, & Sladek CD: Cryopreservation and storage of embryonic rat mesencephalic dopamine neurons for one year: comparison to fresh tissue in culture and neural grafts. Brain Res 623:249–256, 1993 Collier TJ, Gallagher MJ, Sladek CD: Cryopreservation and storage of embryonic rat mesencephalic dopamine neurons for one year: comparison to fresh tissue in culture and neural grafts. Brain Res 623:249–256, 1993
Dong JF, , Detta A, & Hitchcock ER: Susceptibility of human foetal brain tissue to cool- and freeze-storage. Brain Res 621:242–248, 1993 Dong JF, Detta A, Hitchcock ER: Susceptibility of human foetal brain tissue to cool- and freeze-storage. Brain Res 621:242–248, 1993
Durbec P, , Marcos-Gutierrez CV, & Kilkenny C, et al: GDNF signalling through the Ret receptor tyrosine kinase. Nature 381:789–793, 1996 Durbec P, Marcos-Gutierrez CV, Kilkenny C, et al: GDNF signalling through the Ret receptor tyrosine kinase. Nature 381:789–793, 1996
Eggert K, , Schlegel J, & Oertel W, et al: Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro. Neurosci Lett 269:178–182, 1999 Eggert K, Schlegel J, Oertel W, et al: Glial cell line-derived neurotrophic factor protects dopaminergic neurons from 6-hydroxydopamine toxicity in vitro. Neurosci Lett 269:178–182, 1999
Freed CR, , Breeze RE, & Leehey MA, et al: Eight years experience with fetal neurotransplantation in patients with advanced Parkinson's Disease. Soc Neurosci Abstract 22:1210, 1996 (Abstract) Freed CR, Breeze RE, Leehey MA, et al: Eight years experience with fetal neurotransplantation in patients with advanced Parkinson's Disease. Soc Neurosci Abstract 22:1210, 1996 (Abstract)
Freed CR, , Greene PE, & Breeze RE, et al: Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344:710–719, 2001 Freed CR, Greene PE, Breeze RE, et al: Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N Engl J Med 344:710–719, 2001
Freeman TB, , Olanow CW, & Hauser RA, et al: Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 38:379–388, 1995 Freeman TB, Olanow CW, Hauser RA, et al: Bilateral fetal nigral transplantation into the postcommissural putamen in Parkinson's disease. Ann Neurol 38:379–388, 1995
Frodl EM, , Duan WM, & Sauer H, et al: Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function. Brain Res 647:286–298, 1994 Frodl EM, Duan WM, Sauer H, et al: Human embryonic dopamine neurons xenografted to the rat: effects of cryopreservation and varying regional source of donor cells on transplant survival, morphology and function. Brain Res 647:286–298, 1994
Gage FH, , Brundin P, & Isacson O, et al: Rat fetal brain tissue grafts survive and innervate host brain following five day pregraft tissue storage. Neurosci Lett 60:133–137, 1985 Gage FH, Brundin P, Isacson O, et al: Rat fetal brain tissue grafts survive and innervate host brain following five day pregraft tissue storage. Neurosci Lett 60:133–137, 1985
Gage NH, , Dunnett SB, & Stenevi U, et al: Aged rats: recovery of motor impairments by intrastriatal nigral grafts. Science 221:966–969, 1983 Gage NH, Dunnett SB, Stenevi U, et al: Aged rats: recovery of motor impairments by intrastriatal nigral grafts. Science 221:966–969, 1983
Granholm AC, , Mott JL, & Bowenkamp K, et al: Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp Brain Res 116:29–38, 1997 Granholm AC, Mott JL, Bowenkamp K, et al: Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp Brain Res 116:29–38, 1997
Grasbon-Frodl EM, , Nakao N, & Brundin P: The lazaroid U-83836E improves the survival of rat embryonic mesencephalic tissue stored at 4 degrees C and subsequently used for cultures or intracerebral transplantation. Brain Res Bull 39:341–347, 1996 Grasbon-Frodl EM, Nakao N, Brundin P: The lazaroid U-83836E improves the survival of rat embryonic mesencephalic tissue stored at 4 degrees C and subsequently used for cultures or intracerebral transplantation. Brain Res Bull 39:341–347, 1996
Jing S, , Wen D, & Yu Y, et al: GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85:1113–1124, 1996 Jing S, Wen D, Yu Y, et al: GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85:1113–1124, 1996
Juin P, , Pelletier M, & Oliver L, et al: Induction of a caspase-3-like activity by calcium in normal cytosolic extracts triggers nuclear apoptosis in a cell-free system. J Biol Chem 273:17559–17564, 1998 Juin P, Pelletier M, Oliver L, et al: Induction of a caspase-3-like activity by calcium in normal cytosolic extracts triggers nuclear apoptosis in a cell-free system. J Biol Chem 273:17559–17564, 1998
Kawamoto JC, & Barrett JN: Cryopreservation of primary neurons for tissue culture. Brain Res 384:84–93, 1986 Kawamoto JC, Barrett JN: Cryopreservation of primary neurons for tissue culture. Brain Res 384:84–93, 1986
Kearns CM, & Gash DM: GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res 672:104–111, 1995 Kearns CM, Gash DM: GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res 672:104–111, 1995
Kopyov OV, , Jacques D, & Lieberman A, et al: Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease. Cell Transplant 5:327–337, 1996 Kopyov OV, Jacques D, Lieberman A, et al: Clinical study of fetal mesencephalic intracerebral transplants for the treatment of Parkinson's disease. Cell Transplant 5:327–337, 1996
Kopyov OV, , Jacques DS, & Lieberman A, et al: Outcome following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue. Exp Neurol 146:536–545, 1997 Kopyov OV, Jacques DS, Lieberman A, et al: Outcome following intrastriatal fetal mesencephalic grafts for Parkinson's patients is directly related to the volume of grafted tissue. Exp Neurol 146:536–545, 1997
Kordower JH, , Freeman TB, & Snow BJ, et al: Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:1118–1124, 1995 Kordower JH, Freeman TB, Snow BJ, et al: Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N Engl J Med 332:1118–1124, 1995
Kordower JH, , Rosenstein JM, & Collier TJ, et al: Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol 370:203–230, 1996 Kordower JH, Rosenstein JM, Collier TJ, et al: Functional fetal nigral grafts in a patient with Parkinson's disease: chemoanatomic, ultrastructural, and metabolic studies. J Comp Neurol 370:203–230, 1996
Krieglstein K, , Suter-Crazzolara C, & Fischer WH, et al: TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. Embo J 14:736–742, 1995 Krieglstein K, Suter-Crazzolara C, Fischer WH, et al: TGF-beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. Embo J 14:736–742, 1995
Krieglstein K, , Suter-Crazzolara C, & Unsicker K: Development of mesencephalic dopaminergic neurons and the transforming growth factor-beta superfamily. J Neural Transm Suppl 46:209–216, 1995 Krieglstein K, Suter-Crazzolara C, Unsicker K: Development of mesencephalic dopaminergic neurons and the transforming growth factor-beta superfamily. J Neural Transm Suppl 46:209–216, 1995
Levivier M, , Dethy S, & Rodesch F, et al: Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients. Stereotact Funct Neurosurg 69:99–111, 1997 Levivier M, Dethy S, Rodesch F, et al: Intracerebral transplantation of fetal ventral mesencephalon for patients with advanced Parkinson's disease. Methodology and 6-month to 1-year follow-up in 3 patients. Stereotact Funct Neurosurg 69:99–111, 1997
Lin LF, , Doherty DH, & Lile JD, et al: GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130–1132, 1993 Lin LF, Doherty DH, Lile JD, et al: GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130–1132, 1993
Lindvall O, , Brundin P, & Widner H, et al: Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574–577, 1990 Lindvall O, Brundin P, Widner H, et al: Grafts of fetal dopamine neurons survive and improve motor function in Parkinson's disease. Science 247:574–577, 1990
Lopez-Lozano JJ, , Bravo G, & Brera B, et al: Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. Clinica Puerta de Hierro Neural Transplantation Group. J Neurosurg 86:931–942, 1997 Lopez-Lozano JJ, Bravo G, Brera B, et al: Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. Clinica Puerta de Hierro Neural Transplantation Group. J Neurosurg 86:931–942, 1997
Mehta V, , Hong M, & Spears J, et al: Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor. J Neurosurg 88:1088–1095, 1998 Mehta V, Hong M, Spears J, et al: Enhancement of graft survival and sensorimotor behavioral recovery in rats undergoing transplantation with dopaminergic cells exposed to glial cell line-derived neurotrophic factor. J Neurosurg 88:1088–1095, 1998
Mehta V, , Spears J, & Mendez I: Neural transplantation in Parkinson's disease. Can J Neurol Sci 24:292–301, 1997 Mehta V, Spears J, Mendez I: Neural transplantation in Parkinson's disease. Can J Neurol Sci 24:292–301, 1997
Mendez I, , Dagher A, & Hong M, et al: Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line—derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical considerations. J Neurosurg 92:863–869, 2000 Mendez I, Dagher A, Hong M, et al: Enhancement of survival of stored dopaminergic cells and promotion of graft survival by exposure of human fetal nigral tissue to glial cell line—derived neurotrophic factor in patients with Parkinson's disease. Report of two cases and technical considerations. J Neurosurg 92:863–869, 2000
Mendez I, , Dagher A, & Hong M, et al: Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases. J Neurosurg 96:589–596, 2002 Mendez I, Dagher A, Hong M, et al: Simultaneous intrastriatal and intranigral fetal dopaminergic grafts in patients with Parkinson disease: a pilot study. Report of three cases. J Neurosurg 96:589–596, 2002
Mendez I, , Elisevich K, & Flumerfelt B: Dopaminergic innervation of substance P-containing striatal neurons by fetal nigral grafts: an ultrastructural double-labeling immunocytochemical study. J Comp Neurol 308:66–78, 1991 Mendez I, Elisevich K, Flumerfelt B: Dopaminergic innervation of substance P-containing striatal neurons by fetal nigral grafts: an ultrastructural double-labeling immunocytochemical study. J Comp Neurol 308:66–78, 1991
Mendez I, , Elisevich K, & Flumerfelt BA: GABAergic synaptic interactions in the substantia nigra. Brain Res 617:274–284, 1993 Mendez I, Elisevich K, Flumerfelt BA: GABAergic synaptic interactions in the substantia nigra. Brain Res 617:274–284, 1993
Mendez I, , Elisevich K, & Naus C, et al: Restoration of nigrostriatal synaptic circuitry, striatal mRNA expression, and motor symmetry following embryonic substantia nigra grafts. Clin Neurosurg 38:180–209, 1992 Mendez I, Elisevich K, Naus C, et al: Restoration of nigrostriatal synaptic circuitry, striatal mRNA expression, and motor symmetry following embryonic substantia nigra grafts. Clin Neurosurg 38:180–209, 1992
Mendez I, , Sadi D, & Hong M: Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants. J Neurosci 16:7216–7227, 1996 Mendez I, Sadi D, Hong M: Reconstruction of the nigrostriatal pathway by simultaneous intrastriatal and intranigral dopaminergic transplants. J Neurosci 16:7216–7227, 1996
Nakao N, , Frodl EM, & Duan WM, et al: Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc Natl Acad Sci USA 91:12408–12412, 1994 Nakao N, Frodl EM, Duan WM, et al: Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc Natl Acad Sci USA 91:12408–12412, 1994
Nikkhah G, , Eberhard J, & Olsson M, et al: Preservation of fetal ventral mesencephalic cells by cool storage: in-vitro viability and TH-positive neuron survival after microtransplantation to the striatum. Brain Res 687:22–34, 1995 Nikkhah G, Eberhard J, Olsson M, et al: Preservation of fetal ventral mesencephalic cells by cool storage: in-vitro viability and TH-positive neuron survival after microtransplantation to the striatum. Brain Res 687:22–34, 1995
Potter ED, , Ling ZD, & Carvey PM: Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons. Cell Tissue Res 296:235–246, 1999 Potter ED, Ling ZD, Carvey PM: Cytokine-induced conversion of mesencephalic-derived progenitor cells into dopamine neurons. Cell Tissue Res 296:235–246, 1999
Redmond DE Jr, , Leranth C, & Spencer DD, et al: Fetal neural graft survival. Lancet 336:820–822, 1990 Redmond DE Jr, Leranth C, Spencer DD, et al: Fetal neural graft survival. Lancet 336:820–822, 1990
Redmond DE Jr, , Naftolin F, & Collier TJ, et al: Cryopreservation, culture, and transplantation of human fetal mesencephalic tissue into monkeys. Science 242:768–771, 1988 Redmond DE Jr, Naftolin F, Collier TJ, et al: Cryopreservation, culture, and transplantation of human fetal mesencephalic tissue into monkeys. Science 242:768–771, 1988
Sauer H, & Brundin P: Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Restor Neurol Neurosci 2:123–135, 1991 Sauer H, Brundin P: Effects of cool storage on survival and function of intrastriatal ventral mesencephalic grafts. Restor Neurol Neurosci 2:123–135, 1991
Sauer H, , Frodl EM, & Kupsch A, et al: Cryopreservation, survival and function of intrastriatal fetal mesencephalic grafts in a rat model of Parkinson's disease. Exp Brain Res 90:54–62, 1992 Sauer H, Frodl EM, Kupsch A, et al: Cryopreservation, survival and function of intrastriatal fetal mesencephalic grafts in a rat model of Parkinson's disease. Exp Brain Res 90:54–62, 1992
Sauer H, , Rosenblad C, & Bjorklund A: Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc Natl Acad Sci USA 92:8935–8939, 1995 Sauer H, Rosenblad C, Bjorklund A: Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion. Proc Natl Acad Sci USA 92:8935–8939, 1995
Sawada H, , Ibi M, & Kihara T, et al: Neuroprotective mechanism of glial cell line-derived neurotrophic factor in mesencephalic neurons. J Neurochem 74:1175–1184, 2000 Sawada H, Ibi M, Kihara T, et al: Neuroprotective mechanism of glial cell line-derived neurotrophic factor in mesencephalic neurons. J Neurochem 74:1175–1184, 2000
Shults CW, , Kimber T, & Martin D: Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine. Neuroreport 7:627–631, 1996 Shults CW, Kimber T, Martin D: Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine. Neuroreport 7:627–631, 1996
Sinclair SR, , Svendsen CN, & Torres EM, et al: GDNF enhances dopaminergic cell survival and fiber outgrowth in embryonic nigral grafts. Neuroreport 7:2547–2552, 1996 Sinclair SR, Svendsen CN, Torres EM, et al: GDNF enhances dopaminergic cell survival and fiber outgrowth in embryonic nigral grafts. Neuroreport 7:2547–2552, 1996
Sladek JR Jr, , Redmond DE Jr, & Collier TJ, et al: Fetal dopamine neural grafts: extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys. Prog Brain Res 78:497–506, 1988 Sladek JR Jr, Redmond DE Jr, Collier TJ, et al: Fetal dopamine neural grafts: extended reversal of methylphenyltetrahydropyridine-induced parkinsonism in monkeys. Prog Brain Res 78:497–506, 1988
Spencer DD, , Robbins RJ, & Naftolin F, et al: Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 327:1541–1548, 1992 Spencer DD, Robbins RJ, Naftolin F, et al: Unilateral transplantation of human fetal mesencephalic tissue into the caudate nucleus of patients with Parkinson's disease. N Engl J Med 327:1541–1548, 1992
Stromberg I, , Bjorklund L, & Johansson M, et al: Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp Neurol 124:401–412, 1993 Stromberg I, Bjorklund L, Johansson M, et al: Glial cell line-derived neurotrophic factor is expressed in the developing but not adult striatum and stimulates developing dopamine neurons in vivo. Exp Neurol 124:401–412, 1993
Tang FI, , Tien LT, & Zhou FC, et al: Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats. Exp Brain Res 119:287–296, 1998 Tang FI, Tien LT, Zhou FC, et al: Intranigral ventral mesencephalic grafts and nigrostriatal injections of glial cell line-derived neurotrophic factor restore dopamine release in the striatum of 6-hydroxydopamine-lesioned rats. Exp Brain Res 119:287–296, 1998
Tomac A, , Lindqvist E, & Lin LF, et al: Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373:335–339, 1995 Tomac A, Lindqvist E, Lin LF, et al: Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature 373:335–339, 1995
Treanor JJ, , Goodman L, & de Sauvage F, et al: Characterization of a multicomponent receptor for GDNF. Nature 382:80–83, 1996 Treanor JJ, Goodman L, de Sauvage F, et al: Characterization of a multicomponent receptor for GDNF. Nature 382:80–83, 1996
Trupp M, , Arenas E, & Fainzilber M, et al: Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381:785–789, 1996 Trupp M, Arenas E, Fainzilber M, et al: Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 381:785–789, 1996
Trupp M, , Belluardo N, & Funakoshi H, et al: Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. J Neurosci 17:3554–3567, 1997 Trupp M, Belluardo N, Funakoshi H, et al: Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-ret proto-oncogene, and GDNF receptor-alpha indicates multiple mechanisms of trophic actions in the adult rat CNS. J Neurosci 17:3554–3567, 1997
Turner NA, , Xia F, & Azhar G, et al: Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells. J Mol Cell Cardiol 30:1789–1801, 1998 Turner NA, Xia F, Azhar G, et al: Oxidative stress induces DNA fragmentation and caspase activation via the c-Jun NH2-terminal kinase pathway in H9c2 cardiac muscle cells. J Mol Cell Cardiol 30:1789–1801, 1998
Widner H, , Tetrud J, & Rehncrona S, et al: Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). N Engl J Med 327:1556–1563, 1992 Widner H, Tetrud J, Rehncrona S, et al: Bilateral fetal mesencephalic grafting in two patients with parkinsonism induced by 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP). N Engl J Med 327:1556–1563, 1992
Winkler C, , Sauer H, & Lee CS, et al: Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J Neurosci 16:7206–7215, 1996 Winkler C, Sauer H, Lee CS, et al: Short-term GDNF treatment provides long-term rescue of lesioned nigral dopaminergic neurons in a rat model of Parkinson's disease. J Neurosci 16:7206–7215, 1996
Yurek DM: Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue. Exp Neurol 153:195–202, 1998 Yurek DM: Glial cell line-derived neurotrophic factor improves survival of dopaminergic neurons in transplants of fetal ventral mesencephalic tissue. Exp Neurol 153:195–202, 1998
Zawada WM, , Zastrow DJ, & Clarkson ED, et al: Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res 786:96–103, 1998 Zawada WM, Zastrow DJ, Clarkson ED, et al: Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res 786:96–103, 1998
All Time | Past Year | Past 30 Days | |
---|---|---|---|
Abstract Views | 217 | 61 | 4 |
Full Text Views | 550 | 169 | 16 |
PDF Downloads | 40 | 4 | 0 |
EPUB Downloads | 0 | 0 | 0 |